(0.58%) 5 076.00 points
(0.34%) 38 199 points
(0.82%) 17 581 points
(0.75%) $79.59
(2.43%) $1.979
(-0.10%) $2 308.60
(-0.53%) $26.61
(0.46%) $959.30
(0.19%) $0.935
(0.50%) $11.08
(0.12%) $0.799
(-1.47%) $91.89
Live Chart Being Loaded With Signals
Noevir Holdings Co., Ltd. develops, produces, and sells cosmetics, pharmaceuticals, and health food products in Japan, China, Taiwan, South Korea, Hong Kong, Singapore, Thailand, the United States, Canada, and Russia...
Stats | |
---|---|
Šios dienos apimtis | 35 700.00 |
Vidutinė apimtis | 31 942.00 |
Rinkos kapitalizacija | 176.93B |
EPS | ¥0 ( 2024-02-07 ) |
Kita pelno data | ( ¥0 ) 2024-05-08 |
Last Dividend | ¥215.00 ( 2022-09-29 ) |
Next Dividend | ¥0 ( N/A ) |
P/E | 23.60 |
ATR14 | ¥4.83 (0.09%) |
Tūris Koreliacija
Noevir Holdings Co., Ltd. Koreliacija
10 Labiausiai teigiamai susiję koreliacijos |
---|
10 Labiausiai neigiamai susiję koreliacijos |
---|
Ar žinojote?
Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).
Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.
Noevir Holdings Co., Ltd. Koreliacija - Valiuta/Žaliavos
Noevir Holdings Co., Ltd. Finansinės ataskaitos
Annual | 2023 |
Pajamos: | ¥62.55B |
Bruto pelnas: | ¥42.56B (68.05 %) |
EPS: | ¥224.64 |
FY | 2023 |
Pajamos: | ¥62.55B |
Bruto pelnas: | ¥42.56B (68.05 %) |
EPS: | ¥224.64 |
FY | 2022 |
Pajamos: | ¥61.14B |
Bruto pelnas: | ¥42.09B (68.84 %) |
EPS: | ¥222.18 |
FY | 2021 |
Pajamos: | ¥51.27B |
Bruto pelnas: | ¥33.03B (64.42 %) |
EPS: | ¥186.87 |
Financial Reports:
No articles found.
Noevir Holdings Co., Ltd. Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
¥215.00 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | ¥36.00 | 2010-09-15 |
Last Dividend | ¥215.00 | 2022-09-29 |
Next Dividend | ¥0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 14 | -- |
Total Paid Out | ¥1 556.00 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 3.44 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 7.66 | |
Div. Directional Score | 9.32 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Furthermore, its high Dividend Growth Potential Score (DGPS) signals potential dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
8068.T | Ex Dividend Knight | 2024-01-30 | Semi-Annually | 0 | 0.00% | |
7350.T | Ex Dividend Junior | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
6590.T | Ex Dividend Knight | 2024-03-28 | Annually | 0 | 0.00% | |
5936.T | Ex Dividend Junior | 2024-03-28 | Annually | 0 | 0.00% | |
4617.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
3852.T | Ex Dividend Junior | 2023-12-28 | Annually | 0 | 0.00% | |
3093.T | Ex Dividend Knight | 2024-02-28 | Semi-Annually | 0 | 0.00% | |
1967.T | Ex Dividend Junior | 2024-03-18 | Annually | 0 | 0.00% | |
9531.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
8424.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.119 | 1.500 | 7.62 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.105 | 1.200 | 6.52 | 7.82 | [0 - 0.3] |
returnOnEquityTTM | 0.152 | 1.500 | 9.42 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 1.002 | -1.000 | 10.00 | -10.00 | [0 - 1] |
currentRatioTTM | 3.96 | 0.800 | 10.00 | 8.00 | [1 - 3] |
quickRatioTTM | 3.20 | 0.800 | 10.00 | 8.00 | [0.8 - 2.5] |
cashRatioTTM | 1.918 | 1.500 | 0.454 | 0.681 | [0.2 - 2] |
debtRatioTTM | 0.0124 | -1.500 | 9.79 | -10.00 | [0 - 0.6] |
interestCoverageTTM | -11 230 | 1.000 | -10.00 | -10.00 | [3 - 30] |
operatingCashFlowPerShareTTM | 269.79 | 2.00 | 10.00 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 239.78 | 2.00 | 10.00 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.0193 | -1.500 | 9.92 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.679 | 1.000 | 2.01 | 2.01 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.178 | 1.000 | 8.43 | 8.43 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 10.33 | 1.000 | 10.00 | 10.00 | [0.2 - 2] |
assetTurnoverTTM | 0.878 | 0.800 | 7.48 | 5.99 | [0.5 - 2] |
Total Score | 10.99 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 23.59 | 1.000 | 7.72 | 0 | [1 - 100] |
returnOnEquityTTM | 0.152 | 2.50 | 9.63 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 239.78 | 2.00 | 10.00 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 4.25 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 269.79 | 2.00 | 10.00 | 10.00 | [0 - 30] |
payoutRatioTTM | 1.002 | 1.500 | 10.00 | -10.00 | [0 - 1] |
pegRatioTTM | 21.31 | 1.500 | 10.00 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.146 | 1.000 | 8.84 | 0 | [0.1 - 0.5] |
Total Score | 7.66 |
Noevir Holdings Co., Ltd.
Noevir Holdings Co., Ltd. develops, produces, and sells cosmetics, pharmaceuticals, and health food products in Japan, China, Taiwan, South Korea, Hong Kong, Singapore, Thailand, the United States, Canada, and Russia. The company's Cosmetics segment develops, produces, and sells skincare products under various brands, including Noevir and Nameraka Honpo; and NOV hypoallergenic cosmetics, as well as provides contract manufacturing services for cosmetics and quasi drugs. Its Pharmaceutical & Health Food segment produces and sells Nanten Nodo Ame cough drops; functional drinks, such as the Min Min Da Ha; and over-the-counter pharmaceuticals comprising cold remedies, eye drops, and digestive aids, as well as nutritional supplements, and other products. The company's Other segment sells and leases apparels and aircrafts. The company also produces and sells toiletries; purchases and sells makeup products and vessels; and provides market research services. In addition, it provides air transportation, charter flights, ground handling, and hanger rental services; and aircraft flight training, as well as undertakes aviation-related operations. The company sells its products through drug stores, specialty goods and general merchandise stores, supermarkets, online stores, and convenience stores, as well as approximately 2,000 Noevir beauty studios and own retail stores. Noevir Holdings Co., Ltd. was founded in 1964 and is headquartered in Tokyo, Japan.
Apie Signalai gyvai
Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.
Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.